Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT)
Status:
Completed
Trial end date:
1996-02-01
Target enrollment:
Participant gender:
Summary
To test and evaluate the efficacy and safety of intravenous cidofovir (Vistide, previously
known as HPMPC) for the treatment of retinitis.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Johns Hopkins Bloomberg School of Public Health
Collaborators:
Baylor College of Medicine Icahn School of Medicine at Mount Sinai Johns Hopkins University Louisiana State University Health Sciences Center in New Orleans New Jersey Medical School New York University School of Medicine Northwestern University NYU Langone Health University of California, Los Angeles University of California, San Diego University of California, San Francisco University of Miami University of North Carolina, Chapel Hill University of South Florida